Vyant Bio, Inc. Quarterly report pursuant to Section 13 or 15(d)

Contingencies	3 Months Ended
Contingencies	Mar. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies In the normal course of business, the Company may become involved in various claims and legal proceedings. In the opinion of management, the ultimate liability or disposition thereof is not expected to have a material adverse effect on our financial condition, results of operations, or liquidity.